EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Delta-8-tetrahydrocannabinol attenuates colitis and is associated with changes in myeloid cell phenotypes and let-7a-5p expression

Jeffrey I. Garcia-Sanchez, Taylor H. Carter, Urmi Halder, Mitzi Nagarkatti, Prakash Nagarkatti

Frontiers in Pharmacology · 13.11.2026 · 17

DOI: 10.3389/fphar.2026.1973874 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Frontiers in Pharmacology, online erschienen am 13.11.2026. Verfasst von Jeffrey I. Garcia-Sanchez und 4 weiteren Autor:innen. Die Arbeit nennt 50 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Colitis is a form of inflammatory bowel disease characterized by chronic inflammation of the colon. In this study, we investigated the therapeutic potential of Δ8-tetrahydrocannabinol (Δ8-THC), a cannabinoid with lower psychoactive potency than the well-characterized Δ9-THC, in murine models of colitis. Colitis was induced with dextran sulfate sodium (DSS) in C57BL/6J mice or 2,4,6-trinitrobenzenesulfonic acid (TNBS) in BALB/c mice, and Δ8-THC was administered intraperitoneally at 20 mg/kg. Treatment with Δ8-THC significantly attenuated disease severity, as evidenced by improved colonoscopic findings and restoration of colon length. At the cellular level, Δ8-THC reduced the infiltration of myeloid cells and shifted macrophage polarization from a pro-inflammatory M1 phenotype toward an anti-inflammatory M2 phenotype. Exploratory miRNA sequencing in colonic samples identified alterations in regulatory miRNAs, with mmu-let-7a-5p emerging as a key candidate. Differential expression of let-7a-5p was validated by qPCR. In the RAW 264.7 macrophage cell line, mimic and inhibitor experiments showed that manipulation of let-7a-5p modulated Cd86 transcript levels. Computational analyses predicted a potential let-7a-5p–Cd86 interaction. Together, these findings demonstrate that Δ8-THC attenuates colitis, which is associated with increased let-7a-5p expression in the colon, and support a potential role for this miRNA in regulating macrophage-associated inflammatory responses.

Zitieren

APA

Garcia-Sanchez, J. I., Carter, T. H., Halder, U., Nagarkatti, M., & Nagarkatti, P. (2026). Delta-8-tetrahydrocannabinol attenuates colitis and is associated with changes in myeloid cell phenotypes and let-7a-5p expression. Frontiers in Pharmacology, 17. https://doi.org/10.3389/fphar.2026.1973874

Vancouver

Garcia-Sanchez JI, Carter TH, Halder U, Nagarkatti M, Nagarkatti P. Delta-8-tetrahydrocannabinol attenuates colitis and is associated with changes in myeloid cell phenotypes and let-7a-5p expression. Frontiers in Pharmacology. 2026;17. doi:10.3389/fphar.2026.1973874

BibTeX
@article{GarciaSanchez2026,
  author = {Garcia-Sanchez, Jeffrey I. and Carter, Taylor H. and Halder, Urmi and Nagarkatti, Mitzi and Nagarkatti, Prakash},
  title = {Delta-8-tetrahydrocannabinol attenuates colitis and is associated with changes in myeloid cell phenotypes and let-7a-5p expression},
  journal = {Frontiers in Pharmacology},
  year = {2026},
  volume = {17},
  doi = {10.3389/fphar.2026.1973874}
}
Kostenlos starten →